Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basudev Chowdhury

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Iscience|May 12, 2019
PBRM1 Regulates Stress Response in Epithelial CellsElizabeth G Porter, Alisha Dhiman, Basudev Chowdhury, et al.
Cancers|April 13, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple MyelomaBasudev Chowdhury, Swati Garg, Wei Ni, et al.
Cell Chemical Biology|September 11, 2018
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency ReversalChristine A Marian, Mateusz Stoszko, Lili Wang, et al.
Haematologica|June 18, 2026
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemiaEllen Weisberg, Basudev Chowdhury, Swati Garg, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Molecular Therapy. Oncology|April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapyWei Ni, Swati Garg, Basudev Chowdhury, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Iscience|May 12, 2019
PBRM1 Regulates Stress Response in Epithelial CellsElizabeth G Porter, Alisha Dhiman, Basudev Chowdhury, et al.
Cancers|April 13, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple MyelomaBasudev Chowdhury, Swati Garg, Wei Ni, et al.
Cell Chemical Biology|September 11, 2018
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency ReversalChristine A Marian, Mateusz Stoszko, Lili Wang, et al.
Haematologica|June 18, 2026
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemiaEllen Weisberg, Basudev Chowdhury, Swati Garg, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Molecular Therapy. Oncology|April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapyWei Ni, Swati Garg, Basudev Chowdhury, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Pageof 2